Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Keratosis, Actinic 3Glioma 3Glioblastoma 2Carcinoma, Basal Cell 2Brain Neoplasms 2Skin Neoplasms 1Pituitary Neoplasms 1Oligodendroglioma 1Neuroectodermal Tumors 1Neoplasms, Neuroepithelial 1Neoplasms, Basal Cell 1Neoplasms 1Neoplasm, Residual 1Neoplasm Metastasis 1Central Nervous System Neoplasms 1Carcinoma, Squamous Cell 1Astrocytoma 1

Interventions

methyl 5-aminolevulinate 1BF-200 ALA 1Aminolevulinic Acid 15-aminolevulinic acid hexyl ester 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Neoplasms, Basal Cell × Aminolevulinic Acid × Clear all
NCT02367547 2019-03-28

Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL

Joint Authority for Päijät-Häme Social and Health Care

Phase 1/2 Unknown
117 enrolled
Dermatologic

Carcinoma, Basal Cell, Neoplasms, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡